BCBS, Mayo Clinic agree to 5-year collaborative relationship

Blue Cross and Blue Shield of Minnesota and Mayo Clinic will enter a new five-year agreement that will keep all state-wide Mayo Clinic locations within network through 2023.

The collaboration is also meant to determine the “most effective ways to utilize emerging and breakthrough technologies in ways that are sustainable.”

This agreement will help insurers with commercial or government coverage reduce avoidable costs caused by misdiagnosis and excessive treatments.

“Mayo’s openness and willingness to be part of the solution to address rising health care costs is to be commended,” said Garrett Black, senior vice president of health services and enterprise solutions at Blue Cross and Blue Shield of Minnesota in a statement. “Our new agreement was designed with the goal of launching a new kind of long-term strategic relationship that can bring long-term pricing predictability and stability to the market while fostering continued innovation in the way care is accessed, paid for and delivered.”  

The new agreement takes effect on Jan. 1, 2019.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.